Reverdia, a JV powered by DSM and Roquette
Reverdia, a JV powered by DSM and Roquette is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Reverdia, a JV powered by DSM and Roquette.
Reverdia, a JV powered by DSM and Roquette is a company.
Key people at Reverdia, a JV powered by DSM and Roquette.
Key people at Reverdia, a JV powered by DSM and Roquette.
Reverdia was a joint venture between DSM and Roquette focused on producing and commercializing Biosuccinium™, a bio-based succinic acid derived from renewable resources. The company built a commercial-scale plant in Cassano Spinola, Italy, operational since 2012 with a capacity of 10,000 tonnes per year, using low-pH yeast technology to create a sustainable alternative to petroleum-based succinic acid.[1][3][4] It served industries like polyurethanes, automotive, textiles, coatings, resins, and biodegradable plastics (e.g., PBS), solving the problem of reducing environmental impact by offering a high-purity, low-impurity product with a favorable cradle-to-gate life cycle analysis compared to petro-based alternatives.[2][3][6] Reverdia demonstrated early growth by launching production, entering the market, and expanding to licensing in 2014, but was dissolved in April 2019, with operations transferred to Roquette under a DSM license.[2][3][4]
Reverdia emerged from a June 2010 joint venture agreement between Royal DSM N.V., a Dutch life sciences and materials sciences leader, and Roquette Frères, a French starch and derivatives specialist.[1][4][5] The idea stemmed from DSM's development of Biosuccinium™ technology, aiming to commercialize bio-succinic acid at scale using fermentation from renewable feedstocks.[3][4] Key milestones included regulatory approval and official launch in 2011, announcement of the Cassano plant construction in May 2011 (Europe's largest at the time), and operations starting in December 2012.[1][4][8] Early traction came from proving the technology's viability beyond startup phase, with market entry under the Biosuccinium™ brand.[2][3]
Reverdia rode the early 2010s wave of bio-based chemicals, addressing rising demand for renewable alternatives amid fossil fuel dependency and sustainability regulations.[1][3][6] Its timing capitalized on biotechnology advances in fermentation, proving commercial viability when competitors like PTT Global Chemical and BASF were scaling similar plants around 2013.[9] Market forces favoring it included growth in bio-economy sectors (e.g., bioplastics, green materials) driven by LCA benefits and certifications like USDA biobased.[6][7] By validating low-pH yeast tech, Reverdia influenced the ecosystem, paving the way for post-dissolution continuity under Roquette and inspiring industry shifts toward drop-in bio-monomers for existing supply chains.[2][3][6]
Post-2019 dissolution, Biosuccinium™ thrives under Roquette's operations with DSM as exclusive licensor, integrated into global sales for sustained growth in sustainable materials.[2][3][6] Upcoming trends like circular economy mandates, biodegradable plastics demand, and EU Green Deal policies will amplify its role, potentially expanding via Technip Energies' recent tech acquisition signaling broader licensing.[9] Reverdia's legacy as a bio-succinic pioneer endures, powering DSM and Roquette's shift to market-leading technologies in a maturing bio-based economy.[3]
